| Package | au.digitalhealth.cda.schema |
| Resource Type | ValueSet |
| Id | CDAObservationInterpretation |
| FHIR Version | R5 |
| Source | http://ns.electronichealth.net.au/cda/https://build.fhir.org/ig/AuDigitalHealth/cda-au-schema/ValueSet-CDAObservationInterpretation.html |
| URL | http://hl7.org/cda/stds/core/ValueSet/CDAObservationInterpretation |
| Version | 1.0.0 |
| Status | draft |
| Date | 2025-08-07T23:03:06+00:00 |
| Name | CDAObservationInterpretation |
| Title | CDAObservationInterpretation |
| Realm | au |
| Authority | national |
| Description | One or more codes providing a rough qualitative interpretation of the observation - limited to values available in original CDA |
| StructureDefinition | |
| Observation | Observation (CDA Class) |
| ObservationRange | ObservationRange (CDA Class) |
| au-Observation | ADHA Observation (CDA Class) |
| au-ObservationRange | ADHA ObservationRange (CDA Class) |
| CodeSystem | |
| v3-ObservationInterpretation | ObservationInterpretation |
Note: links and images are rebased to the (stated) source
Generated Narrative: ValueSet CDAObservationInterpretation
http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation| Code | Display | Definition |
| B | Better | The current result or observation value has improved compared to the previous result or observation value (the change is significant as defined in the respective test procedure). \[Note: This can be applied to quantitative or qualitative observations.\] |
| D | Significant change down | The current result has decreased from the previous result for a quantitative observation (the change is significant as defined in the respective test procedure). |
| U | Significant change up | The current result has increased from the previous result for a quantitative observation (the change is significant as defined in the respective test procedure). |
| W | Worse | The current result or observation value has degraded compared to the previous result or observation value (the change is significant as defined in the respective test procedure). \[Note: This can be applied to quantitative or qualitative observations.\] |
| < | Off scale low | The result is below the minimum detection limit (the test procedure or equipment is the limiting factor). Synonyms: Below analytical limit, low off scale. |
| > | Off scale high | The result is above the maximum quantifiable limit (the test procedure or equipment is the limiting factor). Synonyms: Above analytical limit, high off scale. |
| A | Abnormal | The result or observation value is outside the reference range or expected norm (as defined for the respective test procedure). \[Note: Typically applies to non-numeric results.\] |
| AA | Critical abnormal | The result or observation value is outside a reference range or expected norm at a level at which immediate action should be considered for patient safety (as defined for the respective test procedure). \[Note: Typically applies to non-numeric results. Analogous to critical/panic limits for numeric results.\] |
| HH | Critical high | The result for a quantitative observation is above a reference level at which immediate action should be considered for patient safety (as defined for the respective test procedure). Synonym: Above upper panic limits. |
| LL | Critical low | The result for a quantitative observation is below a reference level at which immediate action should be considered for patient safety (as defined for the respective test procedure). Synonym: Below lower panic limits. |
| H | High | The result for a quantitative observation is above the upper limit of the reference range (as defined for the respective test procedure). Synonym: Above high normal |
| L | Low | The result for a quantitative observation is below the lower limit of the reference range (as defined for the respective test procedure). Synonym: Below low normal |
| N | Normal | The result or observation value is within the reference range or expected norm (as defined for the respective test procedure). \[Note: Applies to numeric or non-numeric results.\] |
| I | Intermediate | Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with uncertain therapeutic effect. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized\_Terminolo.htm) Projects: ISO 20776-1, ISO 20776-2 \[Note 1: Bacterial strains are categorized as intermediate by applying the appropriate breakpoints in a defined phenotypic test system.\] \[Note 2: This class of susceptibility implies that an infection due to the isolate can be appropriately treated in body sites where the drugs are physiologically concentrated or when a high dosage of drug can be used.\] \[Note 3: This class also indicates a "buffer zone," to prevent small, uncontrolled, technical factors from causing major discrepancies in interpretations.\] \[Note 4: These breakpoints can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).\] |
| MS | moderately susceptible | The patient is considered as carrier based on the testing results. A carrier is an individual who carries an altered form of a gene which can lead to having a child or offspring in future generations with a genetic disorder. ***Deprecation Comment:*** This antimicrobial susceptibility test interpretation concept is recommended by OO to be deprecated as it is no longer recommended for use in susceptibility testing by CLSI (reference CLSI document M100-S22; Vol. 32 No.3; CLSI Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. Jan 2012). |
| R | Resistant | Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic failure. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized\_Terminolo.htm) Projects: ISO 20776-1, ISO 20776-2 \[Note 1: Bacterial strains are categorized as resistant by applying the appropriate breakpoints in a defined phenotypic test system.\] \[Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).\] |
| S | Susceptible | Bacterial strain inhibited by in vitro concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic success. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized\_Terminolo.htm) Synonym (earlier term): Sensitive Projects: ISO 20776-1, ISO 20776-2 \[Note 1: Bacterial strains are categorized as susceptible by applying the appropriate breakpoints in a defined phenotypic system.\] \[Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).\] |
| VS | very susceptible | The patient is considered as carrier based on the testing results. A carrier is an individual who carries an altered form of a gene which can lead to having a child or offspring in future generations with a genetic disorder. ***Deprecation Comment:*** This antimicrobial susceptibility test interpretation concept is recommended by OO to be deprecated as it is no longer recommended for use in susceptibility testing by CLSI (reference CLSI document M100-S22; Vol. 32 No.3; CLSI Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. Jan 2012). |
{
"resourceType": "ValueSet",
"id": "CDAObservationInterpretation",
"text": {
"status": "extensions",
"div": "<!-- snip (see above) -->"
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
"valueInteger": 1,
"_valueInteger": {
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
"valueCanonical": "http://ns.electronichealth.net.au/cda/ImplementationGuide/au.digitalhealth.cda.schema"
}
]
}
}
],
"url": "http://hl7.org/cda/stds/core/ValueSet/CDAObservationInterpretation",
"version": "1.0.0",
"name": "CDAObservationInterpretation",
"title": "CDAObservationInterpretation",
"status": "draft",
"experimental": false,
"date": "2025-08-07T23:03:06+00:00",
"description": "One or more codes providing a rough qualitative interpretation of the observation - limited to values available in original CDA",
"compose": {
"include": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"concept": [
{
"code": "B"
},
{
"code": "D"
},
{
"code": "U"
},
{
"code": "W"
},
{
"code": "<"
},
{
"code": ">"
},
{
"code": "A"
},
{
"code": "AA"
},
{
"code": "HH"
},
{
"code": "LL"
},
{
"code": "H"
},
{
"code": "L"
},
{
"code": "N"
},
{
"code": "I"
},
{
"code": "MS"
},
{
"code": "R"
},
{
"code": "S"
},
{
"code": "VS"
}
]
}
]
}
}